IOM urges international action to eradicate fake drugs

IOM urges international action to eradicate fake drugs
Falsified and substandard medications pose public health problems around the world, and international action should be taken to combat the phenomenon, according to a report published Feb. 13 by the Institute of Medicine.

(HealthDay)—Falsified and substandard medications pose public health problems around the world, and international action should be taken to combat the phenomenon, according to a report published Feb. 13 by the Institute of Medicine (IOM).

Noting that considerable working capital is required to assure the manufacture of quality medicines, Lawrence O. Gostin, J.D., from the Georgetown University Law Center in Washington, D.C., and colleagues from the IOM reviewed the global implications of falsified medicines and recommended measures to eradicate the problem.

According to the authors, to improve the quality of medicine and protect consumers, the distribution system should be strengthened. Restriction of the U.S. wholesale market to firms approved by the National Association of Boards of Pharmacy would tighten the American drug distribution chain and encourage better control of drug wholesalers. In low- and middle-income countries, the governments should establish an appealing environment to encourage reputable private drug sellers. Falsified and substandard medicines often are ineffective, promote , and may cause illness and death, and consequently represent a serious public health concern. Eradicating these drugs will require national regulation and international cooperation. A voluntary international agreement could go some way to achieving this aim.

"Stakeholders around the world share a common interest in combating inferior-quality drugs. At the international level, productive discussion relies on cooperation and mutual trust," the authors write. "The report advocates for an emerging consensus on once-contentious terms and lays out a plan to invest in quality to improve public health."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

Drug shortage crisis puts public health at risk

Dec 11, 2014

Hospitals and pharmacies around the country are facing severe shortages of essential drugs. These shortages can limit access to critical medications and compromise patient safety, resulting in serious illness ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.